MILESTONE MEDICAL, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.58 PLN | -.--% |
|
-.--% | -.--% |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 6.448 | 10.49 | 52.44 | 46.11 | 16.31 | 8.093 |
| Enterprise Value (EV) 1 | 15.35 | 21.51 | 65.99 | 63.12 | 37.59 | 33.61 |
| P/E ratio | -2.45 x | -3.49 x | -15 x | -13.4 x | -3.88 x | -1.66 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 3,224 x | 87.5 x | 1,395 x | 2,918 x | 107 x | 153 x |
| EV / Revenue | 7,676 x | 180 x | 1,755 x | 3,995 x | 247 x | 637 x |
| EV / EBITDA | -6.5 x | -8.32 x | -28.2 x | -18.9 x | -9.17 x | -7.03 x |
| EV / FCF | -12.1 x | -21.6 x | -44.1 x | -29.1 x | -13.9 x | -14 x |
| FCF Yield | -8.3% | -4.64% | -2.27% | -3.44% | -7.18% | -7.14% |
| Price to Book | -0.87 x | -1.01 x | -3.77 x | -2.71 x | -0.78 x | -0.31 x |
| Nbr of stocks (in thousands) | 22,000 | 22,000 | 22,000 | 22,000 | 22,000 | 22,000 |
| Reference price 2 | 0.2931 | 0.4767 | 2.384 | 2.096 | 0.7412 | 0.3679 |
| Announcement Date | 3/21/18 | 3/21/19 | 3/20/20 | 3/19/21 | 3/18/22 | 3/21/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.002 | 0.1198 | 0.0376 | 0.0158 | 0.1522 | 0.0528 |
| EBITDA 1 | -2.362 | -2.587 | -2.342 | -3.333 | -4.099 | -4.784 |
| EBIT 1 | -2.539 | -2.911 | -2.65 | -3.338 | -4.107 | -4.788 |
| Operating Margin | -126,957.15% | -2,430.07% | -7,048.14% | -21,129.19% | -2,698.22% | -9,076.97% |
| Earnings before Tax (EBT) 1 | -2.632 | -3.005 | -3.494 | -3.434 | -4.203 | -4.885 |
| Net income 1 | -2.631 | -3.001 | -3.495 | -3.434 | -4.203 | -4.885 |
| Net margin | -131,528.95% | -2,504.7% | -9,294.43% | -21,734.82% | -2,761.49% | -9,260.83% |
| EPS 2 | -0.1196 | -0.1364 | -0.1588 | -0.1561 | -0.1910 | -0.2220 |
| Free Cash Flow 1 | -1.274 | -0.9972 | -1.497 | -2.173 | -2.698 | -2.4 |
| FCF margin | -63,679.15% | -832.37% | -3,981.57% | -13,750.67% | -1,772.62% | -4,549.55% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/21/18 | 3/21/19 | 3/20/20 | 3/19/21 | 3/18/22 | 3/21/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 8.9 | 11 | 13.6 | 17 | 21.3 | 25.5 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -3.769 x | -4.262 x | -5.787 x | -5.104 x | -5.192 x | -5.334 x |
| Free Cash Flow 1 | -1.27 | -1 | -1.5 | -2.17 | -2.7 | -2.4 |
| ROE (net income / shareholders' equity) | 42.8% | 33.6% | 28.7% | 22.2% | 22.1% | 20.9% |
| ROA (Net income/ Total Assets) | -71.8% | -108% | -168% | -276% | -223% | -300% |
| Assets 1 | 3.663 | 2.79 | 2.077 | 1.246 | 1.881 | 1.627 |
| Book Value Per Share 2 | -0.3400 | -0.4700 | -0.6300 | -0.7700 | -0.9500 | -1.170 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capex | - | 0.01 | - | 0.01 | 0.01 | - |
| Capex / Sales | - | 5.42% | - | 36.35% | 4.26% | - |
| Announcement Date | 3/21/18 | 3/21/19 | 3/20/20 | 3/19/21 | 3/18/22 | 3/21/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 8.59M | |
| -28.51% | 925M | |
| -20.60% | 128M | |
| -7.82% | 67.46M | |
| +6.64% | 60.58M | |
| +14.87% | 61.68M | |
| +0.60% | 51.45M |
- Stock Market
- Equities
- MMD Stock
- Financials Milestone Medical, Inc.
